In the 1970s, an unknown virus was suspected for documented cases of transfusion-
associated hepatitis, a phenomenon called non-A, non-B hepatitis. In 1989, the infectious …

The introduction of efficacious new hepatitis C virus (HCV) treatments galvanized the World
Health Organization to define ambitious targets for eliminating HCV as a public health threat …

Under the terms of this licence, you may copy, redistribute and adapt the work for
noncommercial purposes, provided the work is appropriately cited, as indicated below. In …

These guidelines for the treatment of persons who have or are at risk for sexually transmitted
infections (STIs) were updated by CDC after consultation with professionals knowledgeable …

Abstract Background Direct-acting antivirals (DAAa) cure hepatitis C virus (HCV) infections
in 95% of infected patients. Modeling studies predict that universal HCV treatment will lead …

Abstract Introduction Hepatitis C virus (HCV) is a major public health threat. Although the
recent availability of highly effective directly acting antivirals created optimism towards HCV …

Treatment of chronic hepatitis C virus infection has been revolutionised by the development
of direct-acting antivirals (DAAs). All-oral, once-daily, 8-to 12-week treatment regimens are …

Background The benefits of direct-acting antivirals towards the elimination of hepatitis C
virus (HCV) in people living with HIV are decreased when individuals are reinfected with …

Summary Background In the Netherlands, access to direct-acting antivirals (DAAs) against
hepatitis C virus (HCV) has been unrestricted for chronic infection since 2015. We evaluated …

Abstract The Infectious Diseases Society of America and the American Association for the
Study of Liver Diseases have collaboratively developed evidence-based guidance …